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ABSTRACT 
Objective: The aim of the research work is to develop a new superdisintegrant (starch malonate) which can help in enhancing the solubility and 
drug dissolution of poorly soluble drugs. Hence, starch malonate (new superdisintegrant) was prepared and has been evaluated for its 
superdisintegrant property by incorporating it into fast dissolving tablets of Aceclofenac.  
Methods: Superdisintegrant was developed by using esterification reaction. Prepared starch malonate was then subjected for different 
characterization tests (solubility, pH, melting point, swelling index, FTIR, DSC studies. 23 factorial design method was used to formulate fast 
dissolving tablets of aceclofenac employing starch malonate. Two known superdisintegrants croscarmellose sodium and crospovidone have been 
used along with starch malonate in combinations to develop fast dissolving tablets. Prepared tablets were then subjected to different tests for 
tablets like hardness, friability, disintegration time, dissolution studies. A stability study was performed to determine the stability of the 
formulation. Design expert study was conducted to know the interaction between different superdisintegrants and to select best optimized 
formulation in among all formulations.  
Results: Starch malonate prepared was found to be fine, free flowing slightly crystalline powder, insoluble in aqueous and organic solvents. Tablets 
of all formulations were of excellent quality concerning drug content (100±5%), hardness (3.8-4.2 kg/cm2), and friability (less than 0.15%). In all 
formulations, formulation F2 found to be optimized formulation with least disintegration time 38 S, less wetting time 17±0.08 s and enhanced 
percent dissolved rate in 5 min i.e., 99.84% as compared to other formulations.  
Conclusion: From this it was concluded that starch malonate can be used as a novel superdisintegrant to enhance the drug dissolution of poorly 
soluble drugs. Optimized formulation F2 showed enhanced drug dissolution at 5% concentration as compared to other formulation and showed 
least disintegration time and enhanced drug dissolution as compared to other formulations and pure drug. 
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INTRODUCTION 
Solid oral dosage forms are the most stable and convenient dosage 
form of medicine as they are stable, easy to carry and affordable. 
Formulating a drug in a form which is more presentable and 
affordable is the first choice of physicians and patients.  
Oral solid dosage forms have drug absorption of 50-60% of total 
dosage forms. Solubility is the important parameter which affects the 
drug absorption of solid dosage forms. Solid dosage forms are widely 
accepted because of ease of administration, self-administration and 
low cost. Tablets are the most acceptable and stable dosage forms 
among solid oral dosage forms. These conventional solid dosage forms 
have showed difficulty in swallowing which is common challenge 
faced by old age people and children’s [1].  
Fast dissolving tablets are solid dosage forms which can disintegrate 
very fastly and can be suspended in mouth (saliva). These tablets 
have great advantage for bedridden, unconscious, psychotic, 
pediatric and geriatric patients [2]. 
Different methods are available for the preparation of fast dissolving 
tablets. Direct compression method by using superdisintegrant is 
the most economical and easy method. Superdisintegrants are used 
in fast dissolving tablets in order to disintegrate the tablets quickly. 
As per literature survey, both synthetic and natural 
superdisintegrant are already available in market.  
In the present investigation study, the aim is to prepare a modified 
starch (starch malonate) and utilize it as superdisintegrant in the 
fast dissolving tablets. Starch is well known excipient used as 
disintegrant or binder based on its concentration. Starch has been 
modified by using physical and chemical reaction to modify its 
properties and to give modified starch with better disintegrant 
properties [4]. 
Different types of starch like potato starch, corn starch are 
biomaterials having wide pharmaceutical use and by subjecting it to 
different modification techniques. Corn starch has been used to 
prepare superdisintegrant using different silicates [5, 6]. 
In the present research, potato starch has been modified by esterification 
reaction. Fast dissolving tablets of aceclofenac were prepared by using 
23factorial design employing starch malonate as superdisintegrant for 
enhanced dissolution of aceclofenac, a poorly soluble drug. 
MATERIALS AND METHODS 
Materials 
Aceclofenac, croscarmellose sodium, crospovidone, starch and 
potato starch were purchased from Yarrow chemicals, Mumbai. 
Sodium hydroxide and mannitol were obtained from Finar 
chemicals Ltd, Ahmedabad. Malonic acid was purchased from Liha 
Life sciences Hyderabad. Microcrystalline cellulose was procured 
from Qualigens fine chemicals, Mumbai. Magnesium stearate and 
Talc was purchased from molychem, Mumbai. 
Methods 
Preparation of starch malonate (New superdisintegrant) 
Starch malonate was prepared by using potato starch and malonic 
acid as starting material using esterification [7]. 10 parts of malonic 
acid and 10 parts of potato starch was dissolved in 25 parts of 
distilled water. The pH of the solution was checked and adjusted to 
3.5 by adding 10 M NaOH solution to it. The resultant mixture was 
conditioned for 16 h. After conditioning, the resultant product was 
kept in an oven at 60 °C until it gets dried. In order to remove the 
untreated malonic acid, the mass was washed with distilled water. 
Again, the product was dried in oven at 60 °C until it gets dried. 
Product obtained was grounded and sieved through sieve no.120#.  
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Characterization of starch malonate 
The starch malonate prepared was evaluated for the following 
Solubility 
Solubility of starch malonate was tested in distilled water, aqueous 
buffer of pH 1, 2, 3, 4, 5, 6, and 7.4 and organic solvents such as alcohol, 
dichloromethane, chloroform, acetone and petroleum ether [8].  
pH 
By pH meter, pH of 1% w/v slurry was checked [8].  
Melting point 
Melting point was checked by melting point apparatus [8].  
Viscosity 
The viscosity of 1% dispersion in distilled water was measured 
using Ostwald viscometer [8]. 
Swelling index 
Starch malonate (200 mg) was added to 10 ml of water, and light 
liquid paraffin in two different measuring cylinders and mixed. The 
dispersion in the tubes was allowed to stand for 12 h. The volumes 
of the sediment in the cylinders were recorded. The swelling index 
of the material was calculated as follows [8]. 
 
Test for gelling property 
The gelling property of the starch and starch malonate evaluated by 
heating 7% w/v dispersion of each, in distilled water at 100 °C for 
30 min [8]. 
Particle size 
By optical microscopy, particle size was determined. 
Density 
By using benzene as a liquid, the density (g/cc) measured by liquid 
displacement process [8]. 
Bulk density 
For calculation of loose bulk density (LBD) and tapped bulk density 
(TBD) weighed number of samples were transferred to 50 ml 
measuring cylinder and tapped for about 50 times on a plane 
surface. Tapped volume of packing was recorded. LBD and TBD 
measured by following formula [9]. 
 
 
Percentage compressibility index  
Carr’s compressibility index calculated to check the percent 
compressibility of powder mix. [9]. 
 
Where, TBD = Tapped bulk density; LBD = Loose bulk density. 
Angle of repose 
The angle of repose measured through fixed funnel method [9]. 
Equation used to calculate the angle of repose is given below:  
 
 
Where θ = angle of repose; h = height of pile; r = radius of pile. 
Fourier transform infrared (FTIR) spectroscopy 
FTIR spectra of starch malonate recorded on samples prepared in 
potassium bromide (KBr) disks using a BRUKER FT–IR, (Tokyo, 
Japan). KBr disks of samples were made at 6-8 tons hydrostatic press 
and analyzed sample between scanning range 500 to 4000 cm-1. 
Scanning electron microscopy (SEM) 
Surface morphology of the potato starch and starch malonate was 
confirmed by doing scanning electron microscopy. A double-sided 
sticking carbon tape of 200 nm thickness was used for placing the 
sample on SEM sample stub. Scanning electron photomicrographs 
were recorded at various magnifications to know the surface 
morphology of starch and starch malonate. 
Compatibility studies of selected drug with excipients 
For the formulation of any dosage form, compatibility studies are 
one of the most important steps. Drug should not interact with 
excipients. Our prepared novel superdisintegrant starch malonate 
should not interact with selected drug. Here, we have performed 
compatibility studies by FTIR studies, DSC, TLC studies.  
Infrared spectroscopy 
FTIR studies were performed by IR Spectroscopy method, using KBr 
disc as reference. Drug-excipient mixture was prepared in 1:1 ratio 
and study was performed. FTIR spectra was recorded on samples 
prepared in potassium bromide (KBr) disks using a BRUKER FT–IR, 
(Tokyo, Japan). KBr disks of samples were made at 6-8 tons 
hydrostatic press and analyzed sample between scanning range 500 
to 4000 cm-1. 
Differential scanning calorimetry (DSC) 
Thermogram was recorded on Perkin Elmer Thermal Analyser. 
Thermogram of pure drug (aceclofenac) and excipient drug mixture 
in 1:1 ratio was recorded and compared. 
TLC studies 
Thin layer chromatography (TLC) study 
Stationary Phase: Silica gel H (pre-coated TLC plates). 
Mobile Phase: Toluene: Ethyl Acetate: Glacial Acetic Acid (17.5:10:0.5) 
Procedure 
Mobile phase was prepared as per ratio given and kept in TLC 
chamber undisturbed for 24 h in order to saturate the camber. With 
the help of narrow capillary tube, pure drug, drug with excipient 
were spotted on the activated silica plate. The spotted plates were 
kept in the thin layer chromatography (TLC) chamber and allowed 
to run mobile phase. The plates were dried and kept in iodine 
chamber to develop the spots. Determine the retardation factor (Rf) 
by using the formula given below:  
Retardation factor (RF) = Distance travelled by sample/Distance 
travelled by solvent front. 
Preparation of fast dissolving tablets of aceclofenac  
Table 1 gives the formula for the preparation of fast dissolving 
tablets employing starch malonate. 25 tablets of each formulation 
were prepared to carry out all the tests. Each ingredient was 
weighed accurately as per table 1 and screened through mesh # 120 
before mixing, for uniformity in particle size. In a dried mortar 
pestle all the accurately weighed ingredients were blended to get 
uniformity in particle size. Fast dissolving tablets was compressed 
using 10 mm punches by direct compression method by using by 
using eight station rotatory press Karnawathi Machineries Pvt, Ltd., 
Ahmedabad, India). 
Evaluation of aceclofenac fast dissolving tablets 
Hardness test 
Hardness determines the tablet strength to withstand wear and 
tear while transportation and handling. If tablet is getting 
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breaking down while transportation or while removing from 
packing, there is no use. Aceclofenac fast dissolving tablets are 
determined by using Monsanto hardness tester and expressed in 
units of kg/cm² [9]. 
 
Table 1: Formulae of aceclofenac fast dissolving tablets employing starch malonate prepared by direct compression method 
Ingredients (mg/tablet) F1 F2 F3 F4 F5 F6 F7 F8 
Aceclofenac 100 100 100 100 100 100 100 100 
Starch Malonate --- 25 --- 25 --- 25 --- 25 
Croscarmellose sodium --- --- 25 25 --- --- 25 25 
Crospovidone --- --- --- --- 25 25 25 25 
Mannitol 130 105 105 80 105 80 80 55 
Microcrystalline cellulose 250 250 250 250 250  250 250 250 
Talc 10 10 10 10 10 10 10 10 
Magnesium stearate 10 10 10 10 10 10 10 10 
Total 500 500 500 500 500 500 500 500 
 
Uniformity of weight 
Weight variation test tells the variation in the individual weight of 
tablet from the average weight of 20 tablets. Randomly 20 tablets 
were selected from each formulation and weight variation test was 
performed [9]. 
Friability 
By using Roche friabilator, friability of all tablets was determined. At 25 
rpm tablets were rotated for 4 min or up to 100 revolutions [9]. Tablets 
were weighed again after the removal of fine dust from the tablet 
surface, and weight loss percentage was calculated by the given formula:  
F  
Drug content uniformity 
For content uniformity, ten tablets were weighed and powdered a 
quantity of powder equivalent to 100 mg of aceclofenac was extracted 
into 7.4 phosphate buffer and filtered. The aceclofenac content was 
determined by measuring the absorbance spectrophotometrically at 274 
nm after appropriate dilution with 7.4 phosphate buffer. The drug 
content was calculated as an average of three determinations. 
Wetting time 
Five pieces of circular tissue paper were placed in Petri plate having 
10 cm diameter. Ten ml of water containing a water-soluble dye 
(amaranth) was added to the petri dish. Carefully one tablet was 
kept in the petri plate in and the time taken by colored water to 
reach the upper surface of the tablet was noted as wetting time [10]. 
Water absorption ratio 
The tissue paper was folded twice as per the diameter of the petri 
dish and 6 ml of water was added to the petri dish. A tablet was kept 
on the tissue paper and allowed to wet thoroughly and the wetted 
tablet was weighed. Water absorption ratio was calculated by using 
the given Equation:  
 
Where, 
Wd = Tablet weight after water absorption 
We = Tablet weight before water absorption 
In–vitro disintegration time 
A disintegration time study was performed using USP disintegration 
apparatus having pH 7.4 phosphate buffer as dissolution medium 
maintained at 37±0.2 °C. Time in seconds noted required for 
complete disintegration of the tablets with no palatable mass left in 
the apparatus [11]. 
In–vitro dissolution studies 
The in vitro dissolution studies of aceclofenac fast dissolving tablets 
were performed using 8 stage dissolution test apparatus (Electrolab 
TDT-08L) fitted with paddles (50 rpm) at 37±0.50C, using pH 7.4 
phosphate buffer (900 ml) as a dissolution media. At defined time 
intervals, 5 ml samples were withdrawn, filtered through a 0.45µ 
membrane filter, diluted and assayed at 274 nm using a schimadzu 
UV/Visible double beam spectrophotometer. Cumulative percentage 
drug dissolution was measured using standard absorbance from the 
calibration curve [11]. In vitro dissolution experiments were 
conducted in triplicate (n = 3) 
Stability studies 
As per ICH stability guidelines, stability studies were performed to 
check the changes in the quality of a drug substance or drug product 
with time with respect to various environmental factors like 
temperature, humidity and light stability. Stability studies of F2 
formulation was carried out. The tablets were packed in screw 
capped HDPE bottles and were stored at 40 °C±2 °C and 75% RH for 
6 mo. After storage for 6 mo, the products were tested for drug 
content and drug dissolution rate [11]. 
RESULTS AND DISCUSSION 
The starch malonate prepared was found to be fine, free flowing 
slightly crystalline powder. The physical and micromeritics properties 
of the starch malonate are summarized in table 2. It was insoluble in 
aqueous solvents and insoluble in organic solvents tested (methanol, 
petroleum ether, dichloromethane, and chloroform). The pH of 0.1% 
aqueous dispersion was 3.15. Starch malonate exhibited good swelling 
in water. The swelling index was 83.95%. All micrometric properties 
indicated good flow and compressibility needed for solid dosage form 
manufacturing. The density of starch malonate was found to be 1.008 
g/cc. The angle of repose and compressibility index showed good flow 
properties of starch malonate. 
 
Table 2: Physical and micromeritics properties of the starch 
malonate 
Parameters Observation 
Solubility Insoluble in all aqueous and organic 
solvents tested 
pH (1% w/v aqueous 
dispersion) 
3.15 
Melting Point Charred at 270 °C 
Viscosity (1% w/v 
aqueous dispersion) 
1.022cps 
Swelling index 83.95% 
Gelling property No gelling at 100˚C but formed a clear 
solution. Whereas in the case of starch, 
it was gelatinized and formed gel. 
Particle Size 5.78±2.304 µm (120 mesh) 
Density 1.008 g/cc 
Bulk Density 0.718 g/cc 
Angle of Repose 14.6±0.05  
Compressibility Index 23.02±0.03% 
 
FTIR spectra of potato starch and starch malonate are showed in fig. 
1 and fig. 2. The presence of peak absorption at 1736.63 cm-1, 
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characteristic peak of ester, observed only in the FTIR spectrum of 
starch malonate and is absent in the FTIR spectrum of potato starch. 
So from FTIR studies it was concluded that starch malonate (ester) 
was formed when potato starch was allowed to react with malonic 
acid. The disappearance of pink colour in the ester test confirmed 
the presence of ester, i.e., starch malonate. 
  
 
Fig. 1: FTIR spectra of potato starch 
 
 
Fig. 2: FTIR spectra of starch malonate 
 
 
Fig. 3: X–Ray diffraction of potato starch 
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Fig. 5: Scanning electron microscopy of potato starch 
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The X-ray diffraction pattern of starch and starch malonate given in 
fig. 3 and 4. Fig. 4 i.e., starch malonate showed small characteristic 
peaks, which indicates that the structure is slightly crystalline in 
nature which are absent in potato starch (fig. 3) indicating the 
amorphous nature of potato starch. The scanning electron 
microscopy of the prepared starch malonate also confirmed its 
crystalline nature. Scanning electron microscopic image of potato 
starch and starch malonate showed in fig. 4 and fig. 5. Prepared 
starch malonate was slightly crystalline powder having all the 
characteristic of superdisintegrant. The swelling index of the starch 
malonate was found to be 83.95% indicating that the starch 
malonate was highly swellable and helps in faster disintegration of 






Fig. 6: Scanning electron microscopy of starch malonate 
 
Drug excipient compatibility studies 
The compatibility of starch malonate with the selected drug 
(aceclofenac) was evaluated by FTIR, differential scanning 
calorimetry (DSC) and TLC. 
The FTIR spectra of aceclofenac and aceclofenac–starch malonate 
are shown in fig. 6 and 7. The characteristic peak of–OH, C=O, C-H, 
C=C, NH present in FTIR spectra of aceclofenac and aceclofenac 
plus starch malonate given in table 3. FTIR spectrum of the 
Aceclofenac showed characteristic bands at 1718.17(-C=O), 
1580.55(-C=C), 2968.92 (-OH), 3317.30 (-NH) and 
747.44(Aromatic-Cl) whereas in the FTIR spectrum of aceclofenac-
starch glutamate exhibited same characteristic bands at 1716.07(-
C=O), 1585.10(-C=C), 2970.70 (-OH), 3317.36 (-NH). From the 
FTIR spectra, it was concluded that starch malonate did not show 
any interaction with the selected drug. 
 
Table 3: Characteristic peak present in aceclofenac and aceclofenac plus starch malonate 
Functional group Characteristic peak present in aceclofenac Characteristic peak present in aceclofenac plus starch malonate 
- OH 2968.92 2970.70 
- C=O 1718.17 1716.07 
- C-H 2934.01 2936.44 
- C=C 1580.55 1585.10 
- NH 3317.30 3317.36 
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Fig. 7: FTIR spectra of aceclofenac pure drug 
 
 
Fig. 8: FTIR spectra of aceclofenac with starch malonate 
 
The DSC thermograms of aceclofenac and aceclofenac–starch 
malonate are shown in fig. 8 and 9. The DSC thermograms of 
aceclofenac and aceclofenac–starch malonate exhibited exothermic 
peaks at 152.57˚C and 150.35˚C respectively. These melting peaks of 
aceclofenac and aceclofenac–starch malonate correspond to the 
melting points of aceclofenac (145˚C-165 °C). The peaks observed in 
the DSC thermograms of aceclofenac and aceclofenac–starch 
malonate mixtures correspond to the melting points of the 
respective drug indicating no interactions between the selected drug 
and starch malonate. Thus, the differential scanning calorimetry 




Fig. 9: DSC Thermo gram of aceclofenac pure drug 
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Fig. 10: DSC Thermo gram of aceclofenac with starch malonate 
 
Thin layer chromatography (TLC) plate of aceclofenac and 
aceclofenac-starch malonate is shown in fig. 10. Aceclofenac and 
aceclofenac with starch malonate observed as single spot. 
Retardation factor (Rf) of aceclofenac (0.5) and mixture of 
aceclofenac with starch malonate (0.507) are close indicates that 
there was no interaction between drug and starch malonate. 
 
 
Fig. 11: A) Thin layer chromatography (TLC) plate showing (A) 
Aceclofenac pure drug (B) Aceclofenac and starch malonate 
 
Hardness 
Hardness of fast dissolving tablets of Aceclofenac from all batches 
was found to be in the range of 3.8-4.2 kg/cm2. All the formulations 
prepared employed using starch malonate as superdisintegrant 
possess sufficient hardness to withstand stress during handling, 
transportation and storage.  
Friability 
All the formulation tablets passed the official IP test and possess 
friability between 0.11±0.011 to 0.14±0.011. Weight loss in the 
friability test was less than 0.15% in all formulations. As per IP, 
percent friability below 1% is an indication of good mechanical 
resistance of the tablets. Thus, it was proved that tablets could 
withstand the pressure, mechanical shocks during handling, 
transportation, storage and manufacturing processes.  
Drug content uniformity 
Drug content of all the formulation tablets was found to be within 
97.58±0.71to 99.56±0.57 mg/tablet of the labeled amount. All the 
formulations are having an accurate amount of drug distributed 
uniformly and followed acceptable limits as per IP. Drug content 
uniformity results were tabulated in table 4.  
In vitro disintegration time 
The disintegration time of all the formulated tablets were tabulated 
in table 4 and found to be in the range of 38 to 2000 seconds. The 
disintegration time of the formulated tablets depends on the 
concentration of superdisintegrant used. The formulation containing 
no superdisintegrant was found to have more disintegration time as 
compared to other formulations. Formulation F2 containing novel 
prepared superdisintegrant i. e starch malonate was found to have 
least disintegration time of 38 seconds whereas formulation F8 
containing 5% of three superdisintegrant croscarmellose sodium, 
crospovidone and starch malonate showed disintegration time 49 
seconds. The novel prepared superdisintegrant has showed least 
disintegration time when used alone and in combination as 
compared aceclofenac fast dissolving tablets prepared employing 
sodium starch glycolate, croscarmellose sodium and crospovidone 
by Wagh et al. and aceclofenac tablets prepared employing βCD and 
Kolliphor HS15 by Chowdary et al. [12, 13] 
Water absorption ratio and wetting time 
The water absorption ratio was in between 79.6±0.14 to 148±0.20. 
The wetting time found between 17±0.08-80±0.05 seconds. Results of 
water absorbtion ratio and wetting time of all formulations are given 
in table 4 and wetting time of aceclofenac fast dissolving tablet are 
shown in fig. 11 and fig. 12. Formulation F2containing starch malonate 
alone and formulation F8 containing starch malonate in combination 
showed less wetting time and more water absorption ratio as 
compared to other formulations. The wetting time and water 
absorbtion ratio was found to be good as compared to aceclofenac fast 
dissolving tablets employing different concentrations of Lepidium 
sativum mucilage as natural superdisintegrant by Kaur et al. [14] 
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ratio (%) n±SD 
F1 4.2±0.01 0.13±0.011 97.58±0.71 2000±0.014 80±0.05 79.6±0.14 
F2 4.0±0.03 0.12±0.010 98.10±0.79 38±0.02 17±0.08 140.9±0.017 
F3 3.9±0.01 0.11±0.011 99.45±0.63 60±0.07 47±0.03 137±0.20 
F4 3.8±0.04 0.11±0.012 98.56±0.55 55±0.04 29±0.015 139±0.13 
F5 3.9±0.04 0.13±0.010 99.23±0.56 295±0.01 53±0.011 80.9±0.011 
F6 3.9±0.01 0.14±0.011 99.34±0.18 305±0.03 18±0.14 143±0.010 
F7 3.9±0.02 0.13±0.011 99.56±0.57 305±0.05 35±0.10 126±0.18 
F8 4.0±0.04 0.12±0.012 99.17±0.11 49±0.011 26±0.05 148±0.20 
 Marketed 
formulation 
3.9±0.01  0.15±0.012  99.12±0.11  14±0.04  23±0.19  75±0.27 
*SD Standard Deviation from mean, n=3 
 
  
F1 at T= 0 sec F1 at T=80 seconds 
  
F2 at T= 0 Sec F2 at T= 17 seconds 
  
F3 at T=0 F3 at T= 47 seconds 
  
F4 at T=0 F4 at T= 29 seconds 
  
F5 at T=0 F5 at T= 53 seconds 
Fig. 12: Formulation F1 to F5 wetting time (Starch malonate employing fast dissolving tablets) 
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F6 at T=0 F6 at T= 18 seconds 
  
+F7 at T=0 F7 at T= 35 seconds 
 
 
F8 at T=0 F8 at T= 26 seconds 
Fig. 13: Formulation F6 to F8 wetting time (Starch malonate employing fast dissolving tablets) 
 
In vitro dissolution studies 
USP Type II Paddle apparatus was used to conduct dissolution study. 
Dissolution rate of fast dissolving tablet is inversely related to wetting 
time of the tablet. Optimized formulation F2 containing starch 
malonate alone has showed enhanced drug dissolution and least 
wetting time as compared to other formulations. Formulation (F2) 
contains 5% of starch malonate alone as disintegrant has showed 
enhanced drug dissolution (99.84%) as equivalent to formulation (F8) 
showed 99.94% containing combination of superdisintegrants (starch 
malonate, croscarmellose sodium and crospovidone). Optimized 
formulation F2 was found better and showed enhanced drug 
dissolution than aceclofenac fast dissolving tablets formulation 
prepared by Kumar et al. and by Hazarika et al. [15, 16]. 
This indicated that starch malonate can be used as a 
superdisintegrant to enhance the drug dissolution of poorly soluble 
drugs. Dissolution profiles of all the formulations are shown in fig. 
13. Same results have been observed in case of DE5%, dissolution 
efficiency in 5 min are highest in formulation F2 and F8. Hence, it 
can be understood that F2 is the best formulation as it contains only 
starch malonate as superdisintegrant and showed enhanced drug 




Fig. 14: Dissolution profiles of aceclofenac fast dissolving tablets prepared employing starch malonate (F1-F8) (n =3, mean±SD) 
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Table 5: Dissolution parameters of aceclofenac fast dissolving tablets formulated employing starch malonate 
Time (min) F1 F2 F3 F4 F5 F6 F7 F8 M Marketed  
formulation 
PD5 118.5±0.05 99.84±0.09 85.37±0.02 89.26±0.06 32.78±0.08 99.87±0.03 90.56±0.07 99.94±0.02 73.68±0.13 
DE5% 11.5±0.04  94±0.05 78.7±0.04 84.1±0.04 26.1±0.04 93.9±0.05 83.6±0.07 94.3±0.04 7.4±0.19 
No. of folds 
increase in DE5% 
--- 8.18±0.02 6.84±0.04 7.313±0.09 2.26±0.05 8.165±0.02 7.269±0.03 8.2±0.04 ---- 
*SD standard deviation from mean, n=3, PD5--percent dissolved in 5 min., DE5%-dissolution efficiency in 5 min 
 
To evaluate the individual and combined effects of the three factors 
(starch malonate, croscarmellose sodium and crospovidone) 
involved in the preparation of fast dissolving tablets employing 
selected combinations of the factors as per 23factorial design. The 
fast dissolving tablets and drug dissolution parameters (percent 
drug dissolved in 5 min) of the fast dissolving formulated were 
analyzed as per ANOVA of 23-factorial design. 
ANOVA of fast disintegrating times (table 6), ANOVA of percent 
dissolved in 5 min (table 7), ANOVA of wetting time (table 8), 
ANOVA of water absorption ratio (table 9) and ANOVA of dissolution 
efficiency in 5 min (table 10) indicated that the individual effects of 
starch malonate (A), sodium starch glycolate (B) and crospovidone 
(C) as well as the combined effects of AB, AC, BC and ABC factors 
were significant (P<0.05) on disintegration time, percent dissolved 
in 5 min, wetting time, water absorption ratio and dissolution 
efficiency in 5 min of aceclofenac fast dissolving tablets. 
Fast dissolving tablets formulated employing starch malonate (5%) as 
superdisintegrant exhibited faster disintegration, more percent drug 
dissolution in 5 min, less wetting time, more water absorption ratio 
and more dissolution efficiency in 5 min. On comparison with the 
marketed formulation, the optimized F2 formulation gave drug 
dissolution of 99.84% in 5 min fulfilling the official specification based 
on the disintegration time, percent drug dissolved in 5 min, wetting 
time, water absorption ratio and dissolution efficiency in 5 min. 
The results of disintegration time, percent drug dissolved in 5 min, 
wetting time, water absorption ratio and dissolution parameters like 
dissolution efficiency in 5 min indicated that the optimized 
formulation F2 gave better results as close to marketed formulation. 
 
Table 6: ANOVA of disintegration time of aceclofenac fast dissolving tablets formulated employing starch malonate 
Source of variance Degree of 
freedom 




F ratio Significant/ 
non-significant 
Replicates 2 18.25 9.125 1.334203655 2.77 P<0.05 
Treatments 7 9242255 1320322.143 193049.7128 4.66 P<0.05 
No superdisintegrant 1 3616161 3616161 528733.7232 4.66 P<0.05 
Starch malonate (A) 1 1837067 1837067 268605.0966 4.66 P<0.05 
Croscarmellose sodium (B) 1 1763668 358.8267 52.46552272 4.66 P<0.05 
Starch malonate X 
Croscarmellose sodium (AB) 
1 1074420 1074420 157095.3525 4.66 P<0.05 
Crospovidone (C) 1 542402.7 542402.7 79306.92219 4.66 P<0.05 
Starch malonate X 
crospovidone (AC) 
1 1112843 1112843 162713.3368 4.66 P<0.05 
Croscarmellose sodium X 
crospovidone (BC) 
1 1055882 1055882 154384.8355 4.66 P<0.05 
Starch malonate X 
croscarmellose sodium X 
crospovidone (ABC) 
1 1855928 1855928 271362.8407 4.66 P<0.05 
Error 14 95.75 6.839285714 
   
Total 23 9242369 
    
P<0.05 indicate significance; p>0.05 indicate non-significance, d. f–Degree of Freedom * S. S–Sum of Square * M. S. S–Mean Sum of Squares, All the 
values are expressed as mean±SD, where n=3, SD: Standard Deviation, ANOVA-Analysis of Variance 
 
Table 7: ANOVA of percent dissolved in 5 min of aceclofenac fast dissolving tablets formulated employing starch malonate 
Source of variance Degree of 
freedom 
Sum square Mean sum square 
(sum square/d. f) 




P value  
significance 
Replicates 2 6.925 3.4625 1.01042209 2.77 P>0.05 
Treatments 7 22666.4 3238.057 944.925482 2.77 P<0.05 
No superdisintegrant 1 145115.7 145115.7 42347.4685 4.6 P<0.05 
starch malonate(A) 1 9094.827 9094.827 2654.04019 4.6 P<0.05 
croscarmellose sodium(B) 1 5421.02 5421.02 1581.95477 4.6 P<0.05 
Starch malonate X croscarmellose 
sodium (AB) 
1 7482.189 7482.189 2183.44233 4.6 P<0.05 
Crospovidone (C) 1 491.596 491.596 143.456884 4.6 P<0.05 
Starch malonate X Crospovidone 
(AC) 
1 82.88167 82.88167 24.1864175 4.6 P<0.05 
Croscarmellose X Crospovidone 
(BC) 
1 20.64615 20.64615 6.02493174 4.6 P<0.05 
Starch malonate X Croscarmellose 
sodium X Crospovidone (ABC) 
1 73.22027 73.22027 21.3670408 4.6 P<0.05 
Error 14 47.975 3.426786 
   
Total 23 22721.3 987.8826 
   
P<0.05 indicate significance; p>0.05 indicate non-significance, d. f–Degree of Freedom * S. S–Sum of Square * M. S. S–Mean Sum of Squares, All the 
values are expressed as mean±SD, where n=3, SD: Standard Deviation, ANOVA-Analysis of Variance 
Santosh et al. 
Int J App Pharm, Vol 13, Issue 3, 2021, 87-102 
 
98 
Table 8: ANOVA of wetting time of aceclofenac fast dissolving tablets formulated employing starch malonate 
Source of variance Degree of 
freedom 
Sum square Mean sum square 
(sum square/d. f) 
Variation 
ratio(f)(mss/mss error) 
F ratio Significant/non 
significant 
Replicates 2 45.75 22.875 202.2674162 2.77 P<0.05 
Treatments 7 9334.667 1333.523857 11791.40656 4.66 P<0.05 
No superdisintegrant 1 34656 34656 306438.4513 4.66 P<0.05 
Starch malonate (A) 1 5828.167 5884.402 52031.5973 4.66 P<0.05 
Croscarmellose sodium (B) 1 384 358.8267 3172.850249 4.66 P<0.05 
Starch malonate X 
Croscarmellose sodium (AB) 
1 1837.5 1901.04 16809.54967 4.66 P<0.05 
Crospovidone (C) 1 620.1667 640.6667 5664.961662 4.66 P<0.05 
Starch malonate X 
crospovidone (AC) 
1 486 549.1267 4855.538306 4.66 P<0.05 
Croscarmellose sodium X 
crospovidone (BC) 
1 48.16667 47.60167 420.9078381 4.66 P<0.05 
Starch malonate X 
croscarmellose sodium X 
crospovidone (ABC) 
1 130.6667 135.375 1197.025201 4.66 P<0.05 
Error 14 1.5833 0.113092857 
   
Total 23 9382 
    
P<0.05 indicate significance; p>0.05 indicate non-significance, d. f–Degree of Freedom * S. S–Sum of Square * M. S. S–Mean Sum of Squares, All the 
values are expressed as mean±SD, where n=3, SD: Standard Deviation, ANOVA-Analysis of Variance 
 
Table 9: ANOVA of water absorption ratio of aceclofenac fast dissolving tablets formulated employing starch malonate 
Source of variance Degree of 
freedom 
Sum square Mean sum square 





Replicates 2 0.225 0.1125 0.025204033 2.77 P>0.05 
Treatments 7 41564.93 5937.847143 1330.290606 4.66 P<0.05 
No superdisintegrant 1 369619.4 369619.4 82807.99488 4.66 P<0.05 
Starch malonate (A) 1 8118.082 5884.402 1318.316979 4.66 P<0.05 
Croscarmellose sodium (B) 1 4256.007 358.8267 80.39004321 4.66 P<0.05 
Starch malonate x 
Croscarmellose sodium (AB) 
1 3735.015 1901.04 425.9011042 4.66 P<0.05 
Crospovidone (C) 1 0.081667 640.6667 143.532306 4.66 P<0.05 
Starch malonate X 
crospovidone (AC) 
1 164.3267 549.1267 123.0240647 4.66 P<0.05 
Croscarmellose sodium X 
crospovidone (BC) 
1 9.881667 47.60167 10.6644804 4.66 P<0.05 
Starch malonate X 
croscarmellose sodium X 
crospovidone (ABC) 
1 126.96 135.375 30.32885262 4.66 P<0.05 
Error 14 62.49 4.463571429 - - - 
Total 23 78046.62 
 
- - - 
P<0.05 indicate significance; p>0.05 indicate non-significance, d. f–Degree of Freedom * S. S–Sum of Square * M. S. S–Mean Sum of Squares, All the 
values are expressed as mean±SD, where n=3, SD: Standard Deviation, ANOVA-Analysis of Variance 
 
Table 10: ANOVA of dissolution efficiency in 5 min of aceclofenac fast dissolving tablets formulated employing starch malonate 
Source of variance Degree of 
freedom 
Sum square Mean sum square 





Replicates 2 0.07 0.035 0.162090638 2.77 P>0.05 
Treatments 7 22644.45 3234.921429 14981.44228 4.66 P<0.05 
No superdisintegrant 1 120303.4 120303.4 557144.4261 4.66 P<0.05 
Starch malonate (A) 1 10391.68 10391.68 48125.54416 4.66 P<0.05 
Croscarmellose sodium (B) 1 5005.482 5005.482 23181.19352 4.66 P<0.05 
Starch malonate X 
Croscarmellose sodium (AB) 
1 6733.5 6733.5 31183.92326 4.66 P<0.05 
Crospovidone (C) 1 328.56 328.56 1521.61429 4.66 P<0.05 
Starch malonate X 
crospovidone (AC) 
1 33.135 33.135 153.453523 4.66 P<0.05 
Croscarmellose sodium X 
crospovidone (BC) 
1 0.081667 0.081667 0.378213033 4.66 P<0.05 
Starch malonate X 
croscarmellose sodium X 
crospovidone (ABC) 
1 152.0067 152.0067 703.9675157 4.66 P<0.05 
Error 14 3.023 0.215928571 
   
Total 23 22647.54 
    
P<0.05 indicate significance; p>0.05 indicate non-significance, d. f–Degree of Freedom * S. S–Sum of Square * M. S. S–Mean Sum of Squares, All the 
values are expressed as mean±SD, where n=3, SD: Standard Deviation, ANOVA-Analysis of Variance 
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Design expert study  
Response Surface plot study (Factorial design expert study) 
To co-relate the independent variables (starch malonate (A), 
croscarmellose sodium (B) and crospovidone (C)) with dependent 
variables (disintegration time and dissolution efficiency in 5 min), 
polynomial regression algorithm equation was developed. By 
using Design Expert 7.11 version software, contour plots and 
response surface plots were drawn. Optimized formula was 
selected based on the statistical analysis of equation developed 
and plots dawn,  
Below are the equations 1 and 2 representing polynomial equation 
for disintegration time and dissolution efficiency in 5 min:  
Disintegration time in 5 min =+388.37+276.63 A-271.13B-
149.88C+211.38AB+215.12AC+209.63BC-277.88ABC (R2=1.000) 
Dissolution efficiency in 5 min=+70.78+20.80A+14.40B+3.70C 
16.78AB-1.17AC+0.075BC+2.50ABC (R2=1.000) 
 
Table 11: Effect of starch malonate (A), croscarmellose sodium (B) and crospovidone (C) and their interaction on disintegration time and 
dissolution efficiency in 5 min are given in below 
Parameters Effect of disintegration time  Effect on dissolution efficiency in 5 min 
Starch Malonate (A) + + 
Croscarmellose Sodium (B) - + 
Crospovidone (C) - + 
Starch Malonate (A)+Croscarmellose Sodium (B) + _ 
Starch Malonate (A)+Crospovidone (C) + _ 
Croscarmellose Sodium (B)+Crospovidone (C) + + 
Starch Malonate (A)+Croscarmellose Sodium 
(B)+Crospovidone (C) 
_ + 
+means positive effect, (-) means negative effect, relation between response surface plots and contour plots of interaction between different 
superdisintegrants on disintegration time and dissolution efficiency in 5 min are given in below table 12 and table 13. 
 
Table 12: Effect of different superdisintegrants on disintegration time (From response plots and contour plots-fig. 14 a, 14b, 15 a, 15b, 16 
a, and 16b) 
Superdisintegrants Relation Effect of disintegration time 
Starch malonate (A)+Croscarmellose Sodium 
(B) 
Linear When the concentration of starch malonate and croscarmellose increases, 
disintegration time of tablet decreases. Tablets will disintegrate more rapidly.  
Starch malonate (A)+Crospovidone (C) Linear When the concentration of starch malonate and crospovidone increases, 
disintegration time of tablet decreases. Tablets will disintegrate more rapidly 
Croscarmellose sodium (B)+Crospovidone (C) Linear When the concentration of croscarmellose Sodium and crospovidone increases, 
disintegration time of tablet decreases. Tablets will disintegrate more rapidly 
 
Table 13: Effect of different superdisintegrants on dissolution efficiency in 5 min (From response plots and contour plots-fig. 17 a, 17b, 18 
a, 18b, 19 a, and 19b) 
Superdisintegrants Relation Effect of disintegration time 
Starch malonate (A)+Croscarmellose Sodium (B) Linear Starch malonate in combination with croscarmellose sodium, enhance the 
dissolution efficiency in 5 min.  
Starch malonate (A)+Crospovidone (C) Linear Starch malonate in combination with crospovidone, enhance the dissolution 
efficiency in 5 min. 
Croscarmellose sodium (B)+Crospovidone (C) Linear Croscarmellose sodium in combination with crospovidone, enhance the 
dissolution efficiency in 5 min. 
 
No visible changes were observed in the fast-dissolving tablets after 
storage. Drug dissolution of best optimized formulation (F2) was 
evaluated before and after storage. No difference (P>0.05) was 
observed in the percent drug content before and after storage for 6 
mo. The drug dissolution profiles of the fast-dissolving tablets before 
and after storage are given in table 14 and dissolution profile is 
shown in fig. 20. The drug dissolution characteristics of the 
formulation tested remained unaltered during the storage period. 
The results, thus, indicated that the drug content and drug 
dissolution rate of the fast dissolving tablets formulated employing 
starch malonate were quite stable. Similarity factor (f2) and 
difference factor (f1) were calculated and found to be 56.7 and 4.52 
respectively which is within the limits indicating the similarity 
before and after stability studies. 
 
 
Fig. 15: a) Response surface plot and contour plot of aceclofenac fast dissolving tablets (Effect of starch malonate and croscarmellose 
sodium on disintegration time in five minutes) 
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Table 14: Drug dissolution profile of optimized formulation F2 before and after storage for 6 mo for stability studies 
Optimized formulation Percent drug dissolution 
Formulation F2 (Before stability) 97.88 
Formulation F2 (After stability) 93.45 
 
 
Fig. 16: a) Response surface plot and contour plot of aceclofenac fast dissolving tablets (Effect of starch malonate and crospovidone on 
disintegration time in five minutes) 
 
 
Fig. 17: a) Response surface plot and b) contour plot of aceclofenac fast dissolving tablets (Effect of croscarmellose sodium and 
crospovidone on disintegration time in five minutes) 
 
 
Fig. 18: a) Response surface plot and b) contour plot of aceclofenac fast dissolving tablets (Effect of starch malonate and croscarmellose 
sodium on dissolution efficiency in 5 min) 
 
 
Fig. 19: a) Response surface plot and b) contour plot of aceclofenac fast dissolving tablets (Effect of starch malonate and crospovidone on 
dissolution efficiency in5 min) 
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Fig. 20: a) Response surface plot and b) contour plot of aceclofenac fast dissolving tablets (Effect of starch malonate and crospovidone on 
dissolution efficiency in5 min) 
 
 
Fig. 21: Dissolution profiles of optimized formulation F2 before and after storage for 6 mo 
 
CONCLUSION 
Starch malonate, a modified starch is an efficient superdisintegrant 
for fast dissolving tablets. The disintegration and dissolution 
efficiency of the fast dissolving tablets of Aceclofenac was excellent 
and depended on the concentration of superdisintegrant employed, 
i.e., starch malonate (5%). The formulated fast dissolving tablets of 
aceclofenac employing starch malonate exhibited excellent 
dissolution efficiency in 5 min, which can be used for the faster 
therapeutic action of aceclofenac. When compared to the marketed 
formulation, the optimized, fast dissolving tablet (formulation F2) of 
aceclofenac exhibited excellent dissolution efficiency in 5 min. 
Overall, Starch malonate was found to be a superdisintegrant which 
enhanced the dissolution efficiency of poorly soluble drugs alone or 
in combination with known superdisintegrant crospovidone hence it 
could be used in the formulation of fast dissolving tablets to provide 
immediate drug dissolution of the contained drug within 5 min. 
ABBREVIATION 
M–Molar, NaOH–Sodium Hydroxide, °C-Degree Centigrade, #-
Number, pH-Potential of hydrogen, ml-milliliter, S. I-Swelling Index, 
W/V–Weight/Volume, LBD-Loose bulk density, TBD-Tapped bulk 
density, FTIR-Fourier Transform Infrared Spectra, DSC-Differential 
Scanning Calorimetry, SEM-Scanning Electron Microscopy, TLC–Thin 
Layer Chromatography, HPLC-High Performance Liquid 
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